Adoptive Transfer of Dendritic Cells Expressing Fas Ligand Modulates Intestinal Inflammation in a Model of Inflammatory Bowel Disease.

Edelmarie Rivera de JesusRaymond A IsidroMyrella L CruzHarry MartyCaroline B Appleyard

Published in: Journal of clinical & cellular immunology (2016)

FasL-DCs are effective at treating colonic inflammation in this model of IBD and represent a possible new treatment for patients with IBD.

Keyphrases